One important market in this regard is India, a very important country for the international health care industry. Indian pharma companies already have the highest number of USFDA approved products but have been mainly focused on generics. In the next year and years, it will become one of the more ...
Read more: Outlook 2018 : Investments in R & D essential to keep up with market needs